{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:46:03Z","timestamp":1783485963627,"version":"3.55.0"},"reference-count":37,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T00:00:00Z","timestamp":1130284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective<\/jats:bold> Cardiovascular disease has been reported to be more common in patients with elevated levels of TSH and with normal thyroxine levels, termed subclinical hypothyroidism (SCH). The aim of this study was to determine whether individuals with SCH were more likely than euthyroid controls to have elevations in inflammatory biomarkers that are associated with cardiac disease.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> From the National Health and Nutrition Examination Survey (NHANES) 1999\u20132002 data we identified respondents aged \u2265\u00a040 who met the laboratory criteria for SCH. We compared the average values and frequencies of elevated C\u2010reactive protein (CRP) and homocysteine in the SCH individuals to those in euthyroid individuals.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> A total of 1608 individuals were included in the analysis of whom 45\u00a0(2\u00b78%) met the criteria for SCH, with seven (15\u00b76%) having TSH levels between 10 and 15\u00a0IU\/l. We found no differences in median, mean or the percentage of elevated CRP or homocysteine in individuals with SCH compared to euthyroid controls. Linear regression models adjusting for age, gender, the presence of other cardiac risk factors, and whether the individual was using a cholesterol\u2010lowering drug also failed to show any association between SCH and either high\u2010sensitivity CRP (hsCRP) (<jats:italic>P\u00a0=<\/jats:italic>\u00a00\u00b762) or homocysteine (<jats:italic>P\u00a0=<\/jats:italic>\u00a00\u00b763) levels. When we examined the subset of people with TSH levels between 10 and 15\u00a0IU\/l, we again found no difference in mean hsCRP or homocysteine compared to control.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> In this large population\u2010based sample, hsCRP and homocysteine levels do not differ for individuals with SCH compared to euthyroid individuals. This suggests that cardiac inflammation is not greater in individuals with SCH.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2005.02388.x","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T10:02:08Z","timestamp":1130320928000},"page":"582-587","source":"Crossref","is-referenced-by-count":51,"title":["Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism"],"prefix":"10.1111","volume":"63","author":[{"given":"William J.","family":"Hueston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana E.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Geesey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,10,26]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02615.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archinte.1985.00360080056006","article-title":"The ageing thyroid: thyroid deficiency in the Framingham study","volume":"145","author":"Sawin C.T.","year":"1985","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1977.tb01340.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.4.526"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02598988"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-1-18"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-2-199807150-00016"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-2-199807150-00018"},{"key":"e_1_2_6_10_2","volume-title":"Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force","author":"U.S. Preventive Services Task Force","year":"1996"},{"key":"e_1_2_6_11_2","first-page":"583","article-title":"Thyroid disease in the elderly. Part 2. Predictability of subclinical hypothyroidism","volume":"38","author":"Bemben D.A.","year":"1994","journal-title":"Journal of Family Practice"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:24:1:001"},{"key":"e_1_2_6_13_2","first-page":"155","article-title":"The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20\u2010year follow\u2010study of an English community","volume":"6","author":"Vanderpump M.P.","year":"1996","journal-title":"Thyroid"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-4-200002150-00004"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031089"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-11-200212030-00011"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.2.228"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1231"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1999.v137.92052"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.20.2007"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021993"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.3.237"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.10.1077"},{"key":"e_1_2_6_24_2","unstructured":"National Center for Health Statistics NHANES website:http:\/\/www.cdc.gov\/nchs\/nhanes.htm accessed May 2005."},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.11.1148"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease","volume":"277","author":"Graham I.M.","year":"1997","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/105072502760258721"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/105072502760043512"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1081\/ERC-200033558"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(02)00372-6"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.10.2167"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/67.2.263"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.6.1745"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.12.1971"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.7.713"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.8.731"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00537-2"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02262.x"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2005.02388.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2005.02388.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:49:43Z","timestamp":1697222983000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2005.02388.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,26]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1111\/j.1365-2265.2005.02388.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02388.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,26]]}}}